WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO1993020052) ENANTIOMERIC 1-PHENYL-2-(2-PYRIDINYL)ETHYLAMINE FOR THE TREATMENT OF NEURODEGENERATIVE DISORDERS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/1993/020052    International Application No.:    PCT/GB1993/000689
Publication Date: 14.10.1993 International Filing Date: 01.04.1993
Chapter 2 Demand Filed:    28.05.1993    
IPC:
A61K 31/44 (2006.01), C07D 213/38 (2006.01)
Applicants: FISONS CORPORATION [US/US]; 755 Jefferson Road, Rochester, NY 14623 (US) (AT, AU, BB, BE, BF, BG, BJ, BR, BY, CA, CF, CG, CH, CI, CM, CZ, DE, DK, ES, FI, FR, GA, GB, GN, GR, HU, IE, IT, JP, KP, KR, KZ, LK, LU, MC, MG, ML, MR, MW, NE, NL, NO, NZ, PL, PT, RO, RU, SD, SE, SK, SN, TD, TG, UA, UZ, VN only).
FISONS PLC [GB/GB]; Fison House, Princes Street, Ipswich, Suffolk IP1 1QH (GB) (MN only).
GRIFFITH, Ronald, Conrad [US/US]; (US) (For US Only).
MURRAY, Robert, John [US/US]; (US) (For US Only).
BALESTRA, Michael [US/US]; (US) (For US Only)
Inventors: GRIFFITH, Ronald, Conrad; (US).
MURRAY, Robert, John; (US).
BALESTRA, Michael; (US)
Agent: WRIGHT, Robert, Gordon, McRae; Fisons plc, 12 Derby Road, Loughborough, Leicestershire LE11 0BB (GB)
Priority Data:
9207339.4 03.04.1992 GB
9208290.8 15.04.1992 GB
Title (EN) ENANTIOMERIC 1-PHENYL-2-(2-PYRIDINYL)ETHYLAMINE FOR THE TREATMENT OF NEURODEGENERATIVE DISORDERS
(FR) 1-PHENYL-2-(2-PYRIDINYL)ETHYLAMINE ENANTIOMERE POUR LE TRAITEMENT DE MALADIES DE DEGENERESCENCE DU SYSTEME NERVEUX
Abstract: front page image
(EN)(S)-$g(a)-phenyl-2-pyridineethanamine, and its pharmaceutically acceptable derivatives, are useful in the treatment of neurodegenerative disorders, and exhibit linear pharmacokinetics.
(FR)La (S)-$g(a)-phényl-2(2-pyridinyl)éthylamine et ses dérivés acceptables sur le plan pharmaceutique sont utiles pour le traitement de maladies de dégénérescence du système nerveux et ils présentent un comportement pharmacocinétique linéaire.
Designated States: AT, AU, BB, BG, BR, BY, CA, CH, CZ, DE, DK, ES, FI, GB, HU, JP, KP, KR, KZ, LK, LU, MG, MN, MW, NL, NO, NZ, PL, PT, RO, RU, SD, SE, SK, UA, US, UZ, VN.
European Patent Office (AT, BE, CH, DE, DK, ES, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)